Extended-Duration Betrixaban Reduces the Risk of Rehospitalization Associated With Venous Thromboembolism Among Acutely Ill Hospitalized Medical Patients: Findings From the APEX Trial (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban Trial).


Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Chi, G; Yee, MK; Amin, AN; Goldhaber, SZ; Hernandez, AF; Hull, RD; Cohen, AT; Harrington, RA; Gibson, CM

Published Date

  • January 2, 2018

Published In

Volume / Issue

  • 137 / 1

Start / End Page

  • 91 - 94

PubMed ID

  • 29279341

Pubmed Central ID

  • 29279341

Electronic International Standard Serial Number (EISSN)

  • 1524-4539

Digital Object Identifier (DOI)

  • 10.1161/CIRCULATIONAHA.117.031187


  • eng

Conference Location

  • United States